Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cantor Fitzgerald

Analyst On Cresco's Deal With Columbia Care And Earnings Results For Q4 2021

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00.

This Satellite Semiconductor Firm Looks To Go Public Via SPAC Merger With Endurance

This Satellite Semiconductor Firm Looks To Go Public Via SPAC Merger With Endurance

Bloomberg reports that satellite semiconductor provider SatixFy Communications Ltd agreed to go public via a special purpose acquisition company (SPAC) merger. SatixFy's deal with Endurance Acquisition Corp (NASDAQ:EDNC) will give the combined company a pro forma implied equity value of about $813 million. Israel-based SatixFy is a fabless semiconductor company providing products based on its own…

Cantor Fitzgerald Cuts ADC Therapeutics Price Target On 'Repositioned Zynlonta Pipeline Strategy'

Cantor Fitzgerald Cuts ADC Therapeutics Price Target On 'Repositioned Zynlonta Pipeline Strategy'

Following Q4 FY21 results, Cantor Fitzgerald has lowered the price target on ADC Therapeutics SA (NASDAQ: ADCT) to $26 from $45 and keeps an Overweight rating.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Brief Thoughts Ahead Of 4Q For Curaleaf Holdings: New Jersey Could Be Next Main Catalyst

The Analyst Pablo Zuanic, from Cantor Fitzgerald, kept Curaleaf among the firm’s top picks in the MSO group, with an Overweight rating and a price target at US$16.50. The Thesis

Green Thumb Industries Among Top Cannabis MSO Stocks Ahead Of Earnings Season, Analyst Tells Us Why

As earnings season approaches, Cantor Fitzgerald analyst Pablo Zuanic discussed his expectations. One of his top stock picks, Green Thumb Industries Inc.

Analyst: Dissecting Marijuana Sales Growth And Cannabis Dispensary Performance in Florida

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald takes a close look at Florida's operators regarding store trends and total sales growth. The Florida medical marijuana market has continued to slow in the first quarter of 2022, after mid-teens sequential growth earlier in 2021.

Cannabis Analyst Advises Not To Buy WeedMaps Shares Until March

Cantor Fitzgerald has issued a new report on cannabis tech platform WeedMaps (NASDAQ: MAPS), also known as WM Technology Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Cantor Fitzgerald

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play